Search

Shirley I Miekka

from Colorado Springs, CO
Age ~86

Shirley Miekka Phones & Addresses

  • 5130 Sevenoaks Dr, Colorado Spgs, CO 80919
  • Colorado Springs, CO
  • 11905 Clover Knoll Rd, North Potomac, MD 20878 (301) 977-4054
  • Rockville, MD

Publications

Us Patents

Method Of Inactivating Pathogens

View page
US Patent:
6436344, Aug 20, 2002
Filed:
Nov 2, 1999
Appl. No.:
09/431922
Inventors:
Shirley I. Miekka - Gaithersburg MD
William H. Drohan - Springfield VA
Herbert Baumann - Jarfalla, SE
Ingrid Drevin - Uppsala, SE
Jean-Luc Maloisel - Enebyberg, SE
Assignee:
American National Red Cross - Falls Church VA
Amersham Pharmacia Biotech AB - Uppsala
International Classification:
A01N 100
US Classification:
422 36, 422 17, 422 28, 422 37, 514693
Abstract:
The present invention introduces a class of compounds, 2-substituted carbonyl compounds, that are useful as disinfecting agents, and particularly useful in methods for the disinfection of biological fluids. Members of the class of compounds have been found to possess pathogen inactivating properties against a variety of pathogens. The compounds and methods disclosed herein are useful for disinfecting biological fluids such as blood and blood fractions, among others.

Methods For Sterilizing Biological Materials By Multiple Rates

View page
US Patent:
6682695, Jan 27, 2004
Filed:
Jul 18, 2002
Appl. No.:
10/197248
Inventors:
Martin MacPhee - Montgomery Village MD
William N. Drohan - Springfield VA
Randall S. Kent - Thousand Oaks CA
Tom Lynch - Rockville MD
Glenn Calvert - Frederick MD
Shirley Miekka - Gaithersburg MD
David Mann - Gaithersburg MD
Wilson Burgess - Clifton VA
Assignee:
Clearant, Inc. - Los Angeles CA
International Classification:
A61L 208
US Classification:
422 22, 435408
Abstract:
Methods are disclosed for sterilizing biological materials to reduce the level of one or more biological contaminants or pathogens therein, such as viruses, bacteria (including inter- and intracellular bacteria, such as mycoplasmas, ureaplasmas, nanobacteria, chlamydia, rickettsias), yeasts, molds, fungi, single or multicellular parasites, and/or prions or similar agents responsible, alone or in combination, for TSEs.

Methods Of Production And Use Of Liquid Formulations Of Plasma Proteins

View page
US Patent:
RE38431, Feb 17, 2004
Filed:
Aug 26, 2002
Appl. No.:
10/227411
Inventors:
Shirley I. Miekka - Gaithersburg MD
William N. Drohan - Springfield VA
Thomas R. Jameson - Gaithersburg MD
Manish P. Singh - San Diego CA
Martin J. MacPhee - Montgomery Village MD
Assignee:
The American National Red Cross - Falls Church VA
The Coalition for Hemophilia B - New York NY
International Classification:
A61K 3514
US Classification:
530380, 530383, 530384, 530829, 530830, 514 2, 514 21
Abstract:
The present invention relates to the preparation and use of liquid formulations of plasma proteins, particularly blood coagulation factors. More specifically, the present invention relates to stable liquid formulations of Factor VIII and Factor IX that can be administered by injection or infusion to provide a constant level of the coagulation factor in the blood.

Methods For Sterilizing Biological Materials By Irradiation Over A Temperature Gradient

View page
US Patent:
6908591, Jun 21, 2005
Filed:
Jul 18, 2002
Appl. No.:
10/197249
Inventors:
Martin MacPhee - Montgomery Village MD, US
Glenn Calvert - Frederick MD, US
Tom Lynch - Rockville MD, US
Randall S. Kent - Thousand Oaks CA, US
David Mann - Gaithersburg MD, US
Wilson Burgess - Clifton VA, US
Shirley Miekka - Gaithersburg MD, US
William N. Drohan - Springfield VA, US
Assignee:
Clearant, Inc. - Los Angeles CA
International Classification:
A61L002/08
US Classification:
422 22, 422 21, 422 23, 422 24, 435 11, 435 2
Abstract:
Methods are disclosed for sterilizing tissue to reduce the level of one or more active biological contaminants or pathogens therein, such as viruses, bacteria, (including inter- and intracellular bacteria, such as mycoplasmas, ureaplasmas, nanobacteria, , rickettsias), yeasts, molds, fungi, spores, prions or similar agents responsible, alone or in combination, for TSEs and/or single or multicellular parasites. The methods involve sterilizing one or more tissues with irradiation.

Methods For Sterilizing Biological Materials

View page
US Patent:
6946098, Sep 20, 2005
Filed:
Aug 10, 2001
Appl. No.:
09/925620
Inventors:
Shirley I. Miekka - Gaithersburg MD, US
Wilson Burgess - Clifton VA, US
William N. Drohan - Springfield VA, US
Yuri Griko - Gaithersburg MD, US
Martin J. MacPhee - Montgomery Village MD, US
David M. Mann - Gaithersburg MD, US
Assignee:
Clearant, Inc. - Los Angeles CA
International Classification:
A61L002/08
A01N001/02
US Classification:
422 22, 435 2
Abstract:
Methods are disclosed for sterilizing biological materials to reduce the level therein of one or more biological contaminants or pathogens, such as prions, responsible for the disease states known as transmissible spongiform encephalopathies (TSEs) in mammals. These methods involve sterilizing biological materials with irradiation.

Methods For Sterilizing Preparations Containing Albumin

View page
US Patent:
7252799, Aug 7, 2007
Filed:
Aug 31, 2001
Appl. No.:
09/942941
Inventors:
Shirley I. Miekka - Gaithersburg MD, US
Wilson Burgess - Clifton VA, US
William N. Drohan - Springfield VA, US
Martin J. Macphee - Montgomery Village MD, US
Randall S. Kent - Thousand Oaks CA, US
David M. Mann - Gaithersburg MD, US
Yuri Griko - Gaithersburg MD, US
Assignee:
Clearant, Inc. - Los Angeles CA
International Classification:
A61K 38/46
A61K 39/395
US Classification:
422 22, 424 946, 424 941, 4241761, 422 21, 422 23
Abstract:
Methods are disclosed for sterilizing preparations containing albumin to reduce the level of one or more active biological contaminants or pathogens therein, such as viruses, bacteria (including inter- and intracellular bacteria, such as mycoplasmas, ureaplasmas, nanobacteria, chlamydia, rickettsias), yeasts, molds, fungi, prions or similar agents responsible, alone or in combination, for TSEs and/or single or multicellular parasites. These methods involve sterilizing preparations containing albumin, such as plasma protein fractions, with irradiation.

Methods For Sterilizing Biological Materials Containing Non-Aqueous Solvents

View page
US Patent:
7848487, Dec 7, 2010
Filed:
Nov 3, 2008
Appl. No.:
12/264106
Inventors:
Shirley Miekka - Gaithersburg MD, US
Martin J. Macphee - Montgomery Village MD, US
William N. Drohan - Springfield VA, US
David Mann - Gaithersburg MD, US
Wilson Burgess - Clifton VA, US
Assignee:
Clearant, Inc. - Los Angeles CA
International Classification:
G21K 5/00
US Classification:
378 64
Abstract:
Methods are disclosed for sterilizing biological materials to reduce the level of one or more active biological contaminants or pathogens therein, such as viruses, bacteria (including inter- and intracellular bacteria, such as mycoplasmas, ureaplasmas, nanobacteria, , rickettsias), yeasts, molds, fungi, prions or similar agents responsible, alone or in combination, for TSEs and/or single or multicellular parasites. The methods involve sterilizing biological materials containing one or more non-aqueous solvents with irradiation.

Method Of Inactivating Pathogens

View page
US Patent:
20020187068, Dec 12, 2002
Filed:
Jul 9, 2002
Appl. No.:
10/190852
Inventors:
Shirley Miekka - Gaithersburg MD, US
William Drohan - Springfield VA, US
Herbert Baumann - Jarfalla, SE
Ingrid Drevin - Uppsala, SE
Jean-Luc Maloisel - Enebyberg, SE
Berit Akerlof - Uppsala, SE
International Classification:
A01N001/00
US Classification:
422/036000
Abstract:
The present invention introduces a class of compounds, 2-substituted carbonyl compounds, that are useful as disinfecting agents, and particularly useful in methods for the disinfection of biological fluids. Members of the class of compounds have been found to possess pathogen invactivating properties against a variety of pathogens. The compounds and methods disclosed herein are useful for disinfecting biological fluids such as blood and blood fractions, among others.
Shirley I Miekka from Colorado Springs, CO, age ~86 Get Report